Alimentary Health's Probiotic Technology Launched Nationwide...( CORK Ireland May 12 /- - M...),Health

CORK, Ireland, May 12 /PRNewswire/ --

- Marketed as Align(R) by Procter & Gamble

Alimentary Health Ltd. ("Alimentary Health" or "the Company"), the specialty gastrointestinal company, welcomes today's announcement from its licensing partner Procter & Gamble (P&G), that Align, a daily probiotic supplement clinically proven to naturally defend against episodic digestive upsets, is now available nationwide in the US. Previously only available on-line and through special order from pharmacists, Align is already the US's number one gastroenterologist-recommended probiotic supplement.

Align contains Bifidobacterium infantis 35624, Alimentary Health's probiotic technology trademarked by P&G as Bifantis(R). Bifantis was developed by Alimentary Health, a global leader in the discovery, development and commercialisation of proprietary probiotic and pharmabiotic treatments for GI disorders and other inflammatory conditions, in partnership with P&G. Alimentary Health, founded in 1999 with the support of Enterprise Ireland, is one of the founding partners of the Alimentary Pharmabiotic Centre (APC), a UCC/Teagasc Research Centre focusing on gastrointestinal health and the development of new therapies for debilitating disorders such as Crohn's disease, ulcerative colitis and irritable bowel syndrome. The APC was initially established with funding from Science Foundation Ireland (SFI).

Probiotics are beneficial bacteria that aid digestion and support a more desirable balance of healthy bacteria in the gastrointestinal tract. Align is the only supplement that contains Bifantis, which has been clinically proven to help promote healthy bacteria in the digestive system and to help build and maintain an ongoing natural defence against episodes of digestive imbalance such as constipation, diarrhoea, urgency, gas and bloating.

Bifantis has been independently tested an
'/>"/>